Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study

Background Liposomal amphotericin B (L-AMB) has been used for mucosal leishmaniasis (ML), but comparative studies on L-AMB and other drugs used for the treatment of ML have not been conducted. The present study aimed to evaluate the outcome of patients with ML who were treated with L-AMB. Methods This is a 15-year retrospective study of Brazilian patients with a confirmed diagnosis of ML. The therapeutic options for the treatment of ML consisted of L-AMB, amphotericin B lipid complex (ABLC), deoxycholate amphotericin B (d-AMB), itraconazole, antimonial pentavalent, or pentamidine. Healing, cure rate and adverse effects (AEs) associated with the drugs used to treat this condition were analyzed. Results In 71 patients, a total of 105 treatments were evaluated. The outcome of the treatment with each drug was compared, and results showed that L-AMB was superior to other therapeutic regimens (P = 0.001; odds ratio [OR] = 4.84; 95% confidence interval [CI] = 1.78-13.17). d-AMB had worse AEs than other treatment regimens (P = 0.001, OR = 0.09; 95% CI = 0.09-0.43). Approximately 66% of the patients presented with AEs during ML treatment. Although L-AMB was less nephrotoxic than d-AMB, it was associated with acute kidney injury compared with other drugs (P <0.05). Conclusion L-AMB was more effective than other therapies for the treatment of ML. However, a high incidence of toxicity was associated with its use. Therapeutic choices should be reassessed, and the development of new drugs is necessary for the treatment of ML.

URI

https://observatorio.fm.usp.br/handle/OPI/33494

Referências

Amato V S, 2000, Int J Infect Dis, V4, P153, DOI 10.1016/S1201-9712(00)90077-8
Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x
Amato VS, 2011, AM J TROP MED HYG, V85, P818, DOI 10.4269/ajtmh.2011.11-0287
Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003
Amato VS, 2007, AM J TROP MED HYG, V77, P266, DOI 10.4269/ajtmh.2007.77.266
Amato VS, 2007, CLIN INFECT DIS, V44, P311, DOI 10.1086/510494
Amato VS, 2009, INT J DERMATOL, V48, P1091, DOI 10.1111/j.1365-4632.2009.04099.x
Arning M, 1995, MYCOSES, V38, P459, DOI 10.1111/j.1439-0507.1995.tb00020.x
Aronson N, 2016, CLIN INFECT DIS, V63, pE202, DOI 10.1093/cid/ciw670
Bermudez H, 2006, ANN TROP MED PARASIT, V100, P591, DOI 10.1179/136485906X118495
Boaventura VS, 2006, AM J TROP MED HYG, V75, P267, DOI 10.4269/ajtmh.2006.75.267
Calvopina M, 2004, INT J DERMATOL, V43, P659, DOI 10.1111/j.1365-4632.2004.02183.x
Camargo RA, 2010, AM J TROP MED HYG, V83, P515, DOI 10.4269/ajtmh.2010.10-0081
Castro RM, 1972, AN BRAS DERMATOL, V47, P3
Cunha MA, 2015, AM J TROP MED HYG, V93, P1214, DOI 10.4269/ajtmh.15-0033
de Camargo RA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003001
Galvao EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186117
Guery R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006094
JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73
KAN VL, 1991, J INFECT DIS, V164, P418, DOI 10.1093/infdis/164.2.418
Nonata R, 1997, Trans R Soc Trop Med Hyg, V91, P77
Saenz R E, 1989, Rev Med Panama, V14, P6
Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7
Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265
Solomon M, 2013, J AM ACAD DERMATOL, V68, P284, DOI 10.1016/j.jaad.2012.06.014
Tuon FF, 2013, REV IBEROAM MICOL, V30, P21, DOI 10.1016/j.riam.2012.09.003
Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451
Wortmann G, 2010, AM J TROP MED HYG, V83, P1028, DOI [10.4269/ajtmh.2010.10.0171, 10.4269/ajtmh.2010.10-0171]

Coleções

Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/32
Artigos e Materiais de Revistas Científicas - LIM/46

Página do item completo